(Q44746130)

5 December 2017

title

Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection (English)

1 reference

5 December 2017

1 reference

1 reference

1 reference

1 reference

Ivonette S S Silva

1

1 reference

5 December 2017

Maria Lucia C G Ferraz

2

1 reference

5 December 2017

Renata M Perez

3

1 reference

5 December 2017

Valeria P Lanzoni

4

1 reference

5 December 2017

Virginia M Figueiredo

5

1 reference

5 December 2017

Antonio E B Silva

6

1 reference

5 December 2017

language of work or name

1 reference

1 March 2004

1 reference

Journal of Gastroenterology and Hepatology

5 December 2017

published in

1 reference

5 December 2017

volume

19

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

314-318

1 reference

Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Importance of age in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Clinical, virological, and pathological significance of hepatic bile duct injuries in Chinese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03256.X

10.1111/J.1440-1746.2003.03256.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference